British American Tobacco to Sell Down ITC Stake, Use Funds for Buybacks
By Ian Walker
British American Tobacco plans to sell up to 436.85 million shares of diversified Indian conglomerate ITC and will use the money raised to buyback shares through to December next year.
The FTSE 100 cigarette maker--which houses the Kent, Dunhill and Lucky Strike brands--said Tuesday that it will sell the shares via a bookbuild program, following which it will continue to own 25.5% of ITC. The share sale represents 3.5% of ITC.
BAT will buyback shares through to December 2025 starting with 700 million pounds ($896.9 million) worth of shares this year. It said that the company will continue to use operating cashflow toward its transformation, progressive dividends and reduce debt.
The company said in February that it planned to divest at least part of its 29.02% stake in ITC, a shareholding it has held in some form since the early 1900s.
Shares at 1456 GMT were up 44.50 pence, or 1.9%, at 2,363.50 pence. However, they are currently down 24% over the past 12 months.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
March 12, 2024 11:31 ET (15:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track